C-Jun N-terminal kinases
Overview[edit]
C-Jun N-terminal kinases (JNKs) are a group of mitogen-activated protein kinases (MAPKs) that are involved in regulating various cellular processes, including cell proliferation, apoptosis, and inflammation. JNKs are activated in response to stress stimuli, such as cytokines, ultraviolet radiation, and heat shock.
Structure and Isoforms[edit]
JNKs are encoded by three genes: MAPK8, MAPK9, and MAPK10, which produce ten different isoforms through alternative splicing. These isoforms are categorized into two main groups: JNK1, JNK2, and JNK3. JNK1 and JNK2 are ubiquitously expressed, while JNK3 is primarily found in the brain, heart, and testis.
Activation and Function[edit]
JNKs are activated by phosphorylation through the MAPK kinase (MKK) pathway. The upstream kinases, MKK4 and MKK7, phosphorylate JNKs on threonine and tyrosine residues, leading to their activation. Once activated, JNKs translocate to the nucleus where they phosphorylate transcription factors such as c-Jun, ATF2, and Elk-1.
JNKs play a critical role in the regulation of gene expression in response to stress. They are involved in the apoptotic response to DNA damage, and their activity is crucial for the immune response and inflammatory processes.
Clinical Significance[edit]
Dysregulation of JNK signaling has been implicated in various diseases, including cancer, neurodegenerative disorders, and diabetes. In cancer, JNKs can have both tumor-promoting and tumor-suppressing roles, depending on the context. In neurodegenerative diseases, such as Alzheimer's disease, JNKs contribute to neuronal death and neuroinflammation.
Research and Therapeutic Potential[edit]
Due to their involvement in numerous pathological conditions, JNKs are considered potential targets for therapeutic intervention. Inhibitors of JNKs are being investigated for their potential to treat inflammatory diseases, cancer, and neurodegenerative disorders.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian